Abstract
This paper describes the transformation of the American pharmaceutical industry into its modern configuration in the 1950s. The industry was faced with new regulatory and technological conditions which changed both the way drugs were marketed and what drugs were marketed. The new conditions led to substantially larger drug firms and increased vertical integration, but not to increased concentration or relative profitability in the drug industry. The reasons for this pattern of development stem from the interaction among the FDA's regulations on drug marketing, the limits of patent protection, and the nature of the new technology.
Keywords
EconomicsPharmaceutical industryMarket structureIndustrial organizationMedicinePharmacology
Related Publications
Competitive strategy : techniques for analyzing industries and competitors
Michael Porter presents a comprehensive structural framework and analytical techniques to help a firm to analyze its industry and evolution, understand its competitors and its o...
Antibiotics: past, present and future
The first antibiotic, salvarsan, was deployed in 1910. In just over 100 years antibiotics have drastically changed modern medicine and extended the average human lifespan by 23 ...
Adverse drug reactions in the elderly
Medications probably are the single most important health care technology in preventing illness, disability, and death in the geriatric population. Age-related changes in drug d...
The Visible Hand: The Managerial Revolution in American Business
* Introduction: The Visible Hand * Modern Business Enterprise Defined * Some General Propositions * Part I. The Traditional Processses of Production and Distribution *1. The Tra...
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, struct...
Publication Info
- Year
- 1979
- Type
- article
- Volume
- 10
- Issue
- 2
- Pages
- 429-429
- Citations
- 81
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
81
OpenAlex
Cite This
Peter Temin
(1979).
Technology, Regulation, and Market Structure in the Modern Pharmaceutical Industry.
The Bell Journal of Economics
, 10
(2)
, 429-429.
https://doi.org/10.2307/3003345
Identifiers
- DOI
- 10.2307/3003345